🇺🇸 FDA
Patent

US 6995188

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

expired A61PA61P35/00A61P35/02

Quick answer

US patent 6995188 (S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer) held by The Board of Regents of the University of Texas System expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P35/00, A61P35/02